Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Ahmed Hamdy Insider Profile
4 Followers
Ahmed Hamdy, CMO at Pharmacyclics, holds 1.80M shares in Vincerx Pharma Inc (Ticker: VINC), holds 11.97K shares in Pharmacyclics (Ticker: PCYC). Most recently, Ahmed Hamdy Bought ― shares of Vincerx Pharma Inc on Aug 10, 2023 for an estimated value of 21.02K.
Profitable Transactions
0 out of 5 Profitable Transactions
Average Return
-46.30%
Average return per transaction
Time Frame
Compare to
Insider Roles
CEO, Director
Roles that Ahmed Hamdy holds in companies
Most Profitable Insider Trade
The most profitable trade made by Ahmed Hamdy
Ahmed Hamdy's Trading History
Pharmacyclics
May 03, 2011
―
Uninformative Buy
8.02K
―
Vincerx Pharma Inc
Aug 10, 2023
CEO, Director
Informative Buy
21.02K
$1.58M
List of latest transactions for each holding click on a transaction to see Ahmed Hamdy's performance on stock
You May Also Like
Ahmed Hamdy insider profile FAQ
What is the percentage of profitable transactions made by Ahmed Hamdy?
The percentage of profitable transactions made by Ahmed Hamdy is 0%.
What is the average return per transaction made by Ahmed Hamdy?
The average return per transaction made by Ahmed Hamdy is -46.30%.
What stocks does Ahmed Hamdy hold?
Ahmed Hamdy holds: PCYC, VINC stocks.
What was Ahmed Hamdy’s latest transaction?
Ahmed Hamdy latest transaction was an Informative Buy of $21.02K.
What was Ahmed Hamdy's most profitable transaction?
Ahmed Hamdy’s most profitable transaction was an Informative Buy of VINC stock on June 27, 2022. The return on the trade was -5.00%.
What is Ahmed Hamdy's role in Pharmacyclics?
Ahmed Hamdy's role in Pharmacyclics is CMO.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.